| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT05614531 | Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal… | Spinal Muscular Atrophy Type I | Enrolling by Invitation |
| NCT06819514 | The Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease | Fabry Disease | Not Yet Recruiting |
| NCT07178249 | Evaluating the Safety and Preliminary Efficacy of EXG202 Gene Therapy for Neovascular AMD | Wet Age-related Macular Degeneration | Not Yet Recruiting |
| Early Phase 1 | |||
| NCT06888492 | To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in… | Wet Age-related Macular Degeneration (wAMD) | Not Yet Recruiting |
| NCT06888661 | Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients With Spinal… | Spinal Muscular Atrophy (SMA) | Enrolling by Invitation |
| Not specified | |||
| NCT06859515 | A Long-term Follow up Study of EXG102-031 in Participants With wAMD | Wet Age-related Macular Degeneration | Recruiting |
| NCT06588803 | A Long-term Follow-up Study Evaluating Intravenous Injection of EXG001-307 in Patients… | Spinal Muscular Atrophy | Enrolling by Invitation |